Literature DB >> 12630005

Pattern of recurrence after extended esophagectomy for squamous cell carcinoma of the esophagus.

Ioannis D Kyriazanos1, Mitsuo Tachibana, Muneaki Shibakita, Hiroshi Yoshimura, Shoichi Kinugasa, Dipok K Dhar, Takeru Nakamoto, Toshiyuki Fujii, Naofumi Nagasue.   

Abstract

BACKGROUND/AIMS: To further investigate the underlying mechanism of the systemic spread of esophageal squamous cell carcinoma.
METHODOLOGY: Out of 151 patients who underwent a curative esophageal resection, 41 (27.1%) developed recurrent esophageal cancer. Nine recurrences (22%) were distant-hematogenous, 17 (41.5%) non-hematogenous, and 15 (36.5%) mixed. Hematogenous deposits accompanied 58.5% of the recurrences. The relation between several clinicopathological factors and the pattern of recurrence was evaluated.
RESULTS: Univariate analysis recognized the lack of adjuvant chemoradiation, the tumor location in the lower esophagus and the tumor dedifferentiation as promoting factors for hematogenous recurrence. Poorly differentiated or undifferentiated tumors presented a significantly higher microvessel density than moderately or well differentiated tumors. Tumor differentiation and tumor lower localization were independent predictors of hematogenous recurrence.
CONCLUSIONS: Patients with poorly differentiated or undifferentiated tumors, which are located at the lower esophagus and present high microvessel density, should be considered at high risk for hematogenous recurrences after extended esophagectomy.

Entities:  

Mesh:

Year:  2003        PMID: 12630005

Source DB:  PubMed          Journal:  Hepatogastroenterology        ISSN: 0172-6390


  17 in total

1.  Extramural lymphatic drainage from the thoracic esophagus based on minute cadaveric dissections: fundamentals for the sentinel node navigation surgery for the thoracic esophageal cancers.

Authors:  Hiroyuki Saito; Tatsuo Sato; Masaru Miyazaki
Journal:  Surg Radiol Anat       Date:  2007-08-21       Impact factor: 1.246

2.  Patterns and time of recurrence after complete resection of esophageal cancer.

Authors:  Masahiko Sugiyama; Masaru Morita; Rintaro Yoshida; Koji Ando; Akinori Egashira; Ohga Takefumi; Hiroshi Saeki; Eiji Oki; Yoshihiro Kakeji; Yoshihisa Sakaguchi; Yoshihiko Maehara
Journal:  Surg Today       Date:  2012-02-28       Impact factor: 2.549

3.  Comparison of Two Major Staging Systems in Predicting Survival and Recommendation of Postoperative Radiotherapy Based on the 11th Japanese Classification for Esophageal Carcinoma After Curative Resection: A Propensity Score-Matched Analysis.

Authors:  Xiao Chang; Wei Deng; Wenjie Ni; Chen Li; Weiming Han; Lin-Rui Gao; Shijia Wang; Zongmei Zhou; Dongfu Chen; Qinfu Feng; Nan Bi; Shugeng Gao; Yu Lin; Junqiang Chen; Zefen Xiao
Journal:  Ann Surg Oncol       Date:  2021-05-09       Impact factor: 5.344

4.  Association of the primary tumor location with the site of tumor recurrence after curative resection of thoracic esophageal carcinoma.

Authors:  Yuichiro Doki; Osamu Ishikawa; Ko Takachi; Isao Miyashiro; Yo Sasaki; Hiroaki Ohigashi; Kohei Murata; Terumasa Yamada; Shingo Noura; Hidetoshi Eguchi; Toshiyuki Kabuto; Shingi Imaoka
Journal:  World J Surg       Date:  2005-06       Impact factor: 3.352

5.  Involved-field chemoradiotherapy for postoperative solitary lymph node recurrence of esophageal cancer.

Authors:  Terufumi Kawamoto; Keiji Nihei; Keisuke Sasai; Katsuyuki Karasawa
Journal:  Esophagus       Date:  2018-05-30       Impact factor: 4.230

6.  Salvage concurrent radio-chemotherapy for post-operative local recurrence of squamous-cell esophageal cancer.

Authors:  Jian Zhang; Feng Peng; Na Li; Yongmei Liu; Yong Xu; Lin Zhou; Jin Wang; Jiang Zhu; Meijuan Huang; Youling Gong
Journal:  Radiat Oncol       Date:  2012-06-19       Impact factor: 3.481

7.  Long-term results of radiotherapy combined with nedaplatin and 5-fluorouracil for postoperative loco-regional recurrent esophageal cancer: update on a phase II study.

Authors:  Keiichi Jingu; Haruo Matsushita; Ken Takeda; Rei Umezawa; Chiaki Takahashi; Toshiyuki Sugawara; Masaki Kubozono; Keiko Abe; Takaya Tanabe; Yuko Shirata; Takaya Yamamoto; Youjirou Ishikawa; Kenji Nemoto
Journal:  BMC Cancer       Date:  2012-11-22       Impact factor: 4.430

8.  High dose rate brachytherapy (HDR-BT) in locally advanced oesophageal cancer. Clinic response and survival related to biological equivalent dose (BED).

Authors:  Maria C López Carrizosa; P Maria Samper Ots; A Rodríguez Pérez; A Sotoca; J Sáez Garrido; M M de Miguel
Journal:  Clin Transl Oncol       Date:  2007-06       Impact factor: 3.340

9.  Results of radiation therapy combined with nedaplatin (cis-diammine-glycoplatinum) and 5-fluorouracil for postoperative locoregional recurrent esophageal cancer.

Authors:  Keiichi Jingu; Kenji Nemoto; Haruo Matsushita; Chiaki Takahashi; Yoshihiro Ogawa; Toshiyuki Sugawara; Eiko Nakata; Yoshihiro Takai; Shogo Yamada
Journal:  BMC Cancer       Date:  2006-03-04       Impact factor: 4.430

10.  Neoadjuvant chemoradiotherapy followed by esophagectomy vs. surgery alone in the treatment of resectable esophageal squamous cell carcinoma.

Authors:  Yoshinori Fujiwara; Reigetsu Yoshikawa; Norihiko Kamikonya; Tsuyoshi Nakayama; Kotaro Kitani; Masanori Tsujie; Masao Yukawa; Johji Hara; Takehira Yamamura; Masatoshi Inoue
Journal:  Mol Clin Oncol       Date:  2013-05-21
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.